Tag Archives: SAGE

Top Cheap Stocks To Buy Right Now

“Prepaid wireless” hasn’t always carried the best reputation. Often, what leaps to mind is less-than-stellar coverage, cheap flip phones, or consumers with lousy credit.

MetroPCS is hoping to alter what it insists is an outdated perception with a name change announced Monday, coupled with two new tiered unlimited wireless plans that feature benefits through Amazon Prime and Google One.

Beginning Oct. 8, MetroPCS becomes Metro by T-Mobile, reflecting not only that the prepaid carrier has been owned by the nation’s No. 3 wireless provider since 2013 but that its customers get cell service from the very same network as regular T-Mobile customers and have access to top brand handsets, too, including the latest iPhones.

More: iPhone XS and XS Max review: Apple’s beautiful big-screen beasts exact a small ransom

Top Cheap Stocks To Buy Right Now: Sage Therapeutics, Inc.(SAGE)

Advisors’ Opinion:

  • [By Dan Caplinger]

    Friday was a poor day on Wall Street, as the Dow Jones Industrials fell 200 points and other major benchmarks lost about 1%. Rising bond yields were a major source of consternation among those following the financial markets, with the 10-year Treasury hitting 2.95% and helping to send mortgage rates sharply higher. Even though earnings season has gone fairly well for many companies, some investors are also starting to realize that political issues are likely to cloud the outlook for the U.S. economy in the coming months, creating more uncertainty that could stymie further market gains. Some bad news affecting individual companies also added to the negative mood. Stanley Black & Decker (NYSE:SWK), ManpowerGroup (NYSE:MAN), and Sage Therapeutics (NASDAQ:SAGE) were among the worst performers on the day. Here’s why they did so poorly.

  • [By Joseph Griffin]

    Stevens Capital Management LP bought a new stake in shares of SAGE Therapeutics Inc (NASDAQ:SAGE) in the 2nd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund bought 3,223 shares of the biopharmaceutical company’s stock, valued at approximately $504,000.

  • [By Chris Lange]

    Buy-dip on several “Potential Blockbusters” Aimmune Therapeutics, Inc. (NASDAQ: AIMT), Audentes Therapeutics, Inc. (NASDAQ: BOLD), AveXis, Inc. (NASDAQ: AVXS), Bluebird Bio, Inc. (NASDAQ: BLUE), Esperion Therapeutics, Inc. (NASDAQ: ESPR), and Sage Therapeutics, Inc. (NASDAQ: SAGE) are buy-dip candidates given their bullish trends and favorable technical patterns. Intercept Pharmaceuticals, Inc. (NASDAQ: ICPT), Prothena Corp. PLC (NASDAQ: PRTA), Tesaro, Inc. (NASDAQ: TSRO) and Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) have bearish set-ups. Heron Therapeutics, Inc. (NASDAQ: HRTX) is bigger picture bullish, but may correct further on a move below $19.55. Clovis Oncology, Inc. (NASDAQ: CLVS) has bearish set-up and bulls need to push above $69 to invalidate.

  • [By ]

    Cramer was bearish on Geron (GERN) , Mitek Systems (MITK) , AK Steel Holding (AKS) , Sage Therapeutics (SAGE) and AbbVie (ABBV) .

    Search Jim Cramer’s “Mad Money” trading recommendations using our exclusive “Mad Money” Stock Screener.

Top Cheap Stocks To Buy Right Now: OMNOVA Solutions Inc.(OMN)

Advisors’ Opinion:

  • [By Logan Wallace]

    Get a free copy of the Zacks research report on OMNOVA Solutions (OMN)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Garrett Baldwin]

    Get an exclusive invitation to meet Tim before everyone else right here.

    The Top Stock Market Stories for Wednesday
    The U.S. markets are preparing for the eighth interest rate hike since 2015, and the Federal Reserve may not be done yet. Markets are weighing the possibility that the Fed may raise rates one more time this year (in December). The hikes come as the Fed is attempting to shrink its $4.5 trillion balance sheet. When Powell speaks this afternoon, expect a few questions about the impact of the trade war between the United States and China. Reporters will also likely want to know about geopolitical risks to the U.S. economy and how they might affect growth in a higher-interest-rate environment. Yesterday, U.S. President Donald Trump gave a speech before the United Nations General Assembly. During his talk, Trump praised the U.S. economy and defended his administration’s actions this year on trade. Trump said that the United States will no longer endure “abuse” from other trade partners. The U.S. Trade Representative Robert Lighthizer also said Tuesday that the U.S. is prepared to proceed on a new trade deal with Mexico without the participation of Canada. Oil prices are in focus after President Trump called out OPEC members before the U.N. on Tuesday. During his talk, Trump accused OPEC and non-OPEC participants in collusion efforts on production and prices of ripping off the rest of the world.
    Three Stocks to Watch Today: NKE, SVMK, DB
    Shares of Nike Inc. (NYSE: NKE) fell 3.5% after the sports apparel giant reported earnings after the bell. The company topped earnings expectations and reported profit growth of 15%. However, investors took some profits off the table. Shares of Nike stock are up more than 35% on the year. SVMK, the parent company of SurveyMonkey, has priced its upcoming IPO at $12 per share. That figure is above analysts’ initial range expectation of $9 to $11 per share. The firm expects to reach a market capitalization of $1.46 bil

  • [By Joseph Griffin]

    OMNOVA Solutions Inc. (NYSE:OMN) – Analysts at KeyCorp issued their Q2 2019 earnings estimates for shares of OMNOVA Solutions in a report issued on Wednesday, February 6th. KeyCorp analyst M. Sison expects that the specialty chemicals company will post earnings per share of $0.17 for the quarter. KeyCorp also issued estimates for OMNOVA Solutions’ Q3 2019 earnings at $0.18 EPS.

  • [By Motley Fool Transcribing]

    OMNOVA Solutions (NYSE:OMN) Q3 2018 Earnings Conference CallSep. 26, 2018 11:00 a.m. ET

    Contents:
    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:

    Operator

  • [By Motley Fool Staff]

    OMNOVA Solutions (NYSE:OMN) Q2 2018 Earnings Conference CallJun. 28, 2018 11:00 a.m. ET

    Contents:
    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:

    Operator

Top Cheap Stocks To Buy Right Now: Unilever NV(UN)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Wrapmanager Inc. grew its stake in shares of Unilever NV (NYSE:UN) by 28.5% in the second quarter, HoldingsChannel.com reports. The firm owned 5,291 shares of the company’s stock after buying an additional 1,173 shares during the quarter. Wrapmanager Inc.’s holdings in Unilever were worth $295,000 at the end of the most recent quarter.

  • [By Max Byerly]

    Cullen Frost Bankers Inc. acquired a new stake in Unilever NV (NYSE:UN) during the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The fund acquired 5,972 shares of the company’s stock, valued at approximately $321,000.

  • [By John Ballard]

    There is a lot to like about Procter & Gamble (NYSE:PG) and Unilever (NYSE:UN). These companies make products that people all over the world use every day, and both are good dividend payers.

  • [By Ethan Ryder]

    ETRADE Capital Management LLC increased its holdings in Unilever (NYSE:UN) by 20.7% in the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 27,787 shares of the company’s stock after buying an additional 4,767 shares during the period. ETRADE Capital Management LLC’s holdings in Unilever were worth $1,567,000 as of its most recent filing with the Securities and Exchange Commission.

Best Clean Energy Stocks To Invest In Right Now

Freshman Congress member Alexandria Ocasio-Cortez and veteran lawmaker Sen. Edward Markey are introducing a resolution spelling out congressional support for a Green New Deal — an ambitious plan to remake the U.S. economy and drastically reduce the nation’s greenhouse gas emissions.

The resolution largely sticks to a blueprint Ocasio-Cortez laid out when she proposed creating a House select committee to establish a Green New Deal. That framework called for generating 100 percent of the nation’s power from renewable sources, making all buildings energy efficient and eliminating carbon dioxide and other greenhouse gas emissions from the transportation sector and industry — all within about 10 years.

The plan also proposes massive investments in research and development to make the U.S. a leader in clean energy technology. In addition, the Green New Deal envisioned by Ocasio-Cortez aims to implement progressive policies such as a federal jobs guarantee, basic income and universal health care.

Best Clean Energy Stocks To Invest In Right Now: Asbury Automotive Group Inc(ABG)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Arizona State Retirement System lifted its position in shares of Asbury Automotive Group, Inc. (NYSE:ABG) by 2.2% in the fourth quarter, Holdings Channel reports. The fund owned 30,187 shares of the company’s stock after buying an additional 662 shares during the period. Arizona State Retirement System’s holdings in Asbury Automotive Group were worth $2,012,000 at the end of the most recent quarter.

  • [By Jon C. Ogg]

    Asbury Automotive Group Inc. (NYSE: ABG) was raised to Equal Weight from Underweight at Morgan Stanley, which also raised the price target to $71 from $63. Asbury shares previously closed at $72.40, but they were down 1.1% at $71.60 on Tuesday morning. The 52-week trading range is $49.10 to $76.50, and the previous consensus analyst target price was $75.86.

  • [By Logan Wallace]

    Asbury Automotive Group (NYSE:ABG) will post its quarterly earnings results before the market opens on Wednesday, February 6th. Analysts expect Asbury Automotive Group to post earnings of $2.06 per share for the quarter.

  • [By Lisa Levin] Companies Reporting Before The Bell
    United Technologies Corporation (NYSE: UTX) is estimated to report quarterly earnings at $1.51 per share on revenue of $14.62 billion.
    The Coca-Cola Company (NYSE: KO) is expected to report quarterly earnings at $0.46 per share on revenue of $7.31 billion.
    Caterpillar Inc. (NYSE: CAT) is projected to report quarterly earnings at $2.07 per share on revenue of $11.93 billion.
    Verizon Communications Inc. (NYSE: VZ) is expected to report quarterly earnings at $1.11 per share on revenue of $31.22 billion.
    Lockheed Martin Corporation (NYSE: LMT) is estimated to report quarterly earnings at $3.42 per share on revenue of $11.28 billion.
    The Sherwin-Williams Company (NYSE: SHW) is projected to report quarterly earnings at $3.15 per share on revenue of $3.94 billion.
    Biogen Inc. (NASDAQ: BIIB) is expected to report quarterly earnings at $5.92 per share on revenue of $3.15 billion.
    3M Company (NYSE: MMM) is estimated to report quarterly earnings at $2.52 per share on revenue of $8.26 billion.
    JetBlue Airways Corporation (NASDAQ: JBLU) is projected to report quarterly earnings at $0.2 per share on revenue of $1.75 billion.
    Eli Lilly and Company (NYSE: LLY) is expected to report quarterly earnings at $1.13 per share on revenue of $5.49 billion.
    Harley-Davidson, Inc. (NYSE: HOG) is estimated to report quarterly earnings at $0.88 per share on revenue of $1.25 billion.
    Corning Incorporated (NYSE: GLW) is expected to report quarterly earnings at $0.3 per share on revenue of $2.50 billion.
    Centene Corporation (NYSE: CNC) is projected to report quarterly earnings at $1.88 per share on revenue of $13.28 billion.
    The Travelers Companies, Inc. (NYSE: TRV) is estimated to report quarterly earnings at $2.77 per share on revenue of $6.75 billion.
    Wipro Limited (NYSE: WIT) is expected to report quarterly earnings at $0.07 per share on revenue of $2.16 billion.
    PACCAR Inc (NASDAQ: PCAR) is projected to
  • [By Rich Smith]

    The three car dealers SunTrust reviewed this morning are Asbury Automotive Group (NYSE:ABG), AutoNation (NYSE:AN), and Penske Automotive Group (NYSE:PAG).

  • [By Jon C. Ogg]

    Asbury Automotive Group Inc. (NYSE: ABG) was started as Hold and assigned a $78 target price (versus a $75.75 close) at SunTrust Robinson Humphrey.

Best Clean Energy Stocks To Invest In Right Now: Crestwood Equity Partners LP(CEQP)

Advisors’ Opinion:

  • [By Reuben Gregg Brewer]

    For example, relatively small peer Crestwood Equity Partners LP (NYSE:CEQP) ended the month up 13%. ONEOK (NYSE:OKE), which is structured as a regular corporation and not a limited partnership, rose an impressive 19%. And Canadian midstream owner Pembina Pipeline (NYSE:PBA) jumped 20% (like ONEOK, Pembina is not structured as a limited partnership). The midstream sector across the board had a pretty decent month.

  • [By Shane Hupp]

    Luzich Partners LLC raised its position in shares of Crestwood Equity Partners LP (NYSE:CEQP) by 5.2% during the first quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 581,601 shares of the pipeline company’s stock after acquiring an additional 28,640 shares during the period. Crestwood Equity Partners makes up about 14.6% of Luzich Partners LLC’s investment portfolio, making the stock its 2nd largest position. Luzich Partners LLC’s holdings in Crestwood Equity Partners were worth $14,889,000 at the end of the most recent reporting period.

  • [By Matthew DiLallo]

    Crestwood Equity Partners (NYSE:CEQP), Oasis Midstream Partners (NYSE:OMP), and Hess Midstream Partners (NYSE:HESM) are far from household names. Because of that, most investors probably missed the fact that these high-yielding master limited partnerships (MLPs) have been red-hot this year. However, while all have delivered strong returns in 2018, each one still has plenty of fuel left in the tank to continue providing outsized gains in the coming years, which is why investors won’t want to keep overlooking the potential of these pipeline companies.

Best Clean Energy Stocks To Invest In Right Now: Axsome Therapeutics, Inc.(AXSM)

Advisors’ Opinion:

  • [By Max Byerly]

    Axsome Therapeutics (NASDAQ:AXSM) released its quarterly earnings results on Tuesday. The company reported ($0.19) earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of ($0.28) by $0.09, Bloomberg Earnings reports.

  • [By Lisa Levin] Gainers
    Comstock Resources, Inc. (NYSE: CRK) shares shot up 52 percent to $7.235 after the company disclosed a deal with Arkoma Drilling L.P. and Williston Drilling, L.P. to buy oil & gas properties in North Dakota. Comstock announced withdrawal of tender offers for outstanding secured notes.
    MarineMax, Inc. (NYSE: HZO) shares gained 24.2 percent to $21.80 as the company posted upbeat Q2 results and raised its FY18 outlook.
    Mattersight Corporation (NASDAQ: MATR) shares rose 22 percent to $2.625 after the company agreed to be purchased by NICE Ltd.
    Chipotle Mexican Grill, Inc. (NYSE: CMG) jumped 21.3 percent to $411.871 as the company reported stronger-than-expected results for its first quarter on Wednesday.
    Axsome Therapeutics, Inc. (NASDAQ: AXSM) rose 17 percent to $3.10 after the company disclosed a positive outcome of the interim analysis of STRIDE-1 Phase 3 trial of AXS-05 in treatment resistant depression.
    Ultra Clean Holdings, Inc. (NASDAQ: UCTT) rose 15.9 percent to $18.34 following upbeat Q1 earnings.
    PCM, Inc. (NASDAQ: PCMI) gained 15.6 percent to $12.20 following Q1 results.
    O'Reilly Automotive, Inc. (NASDAQ: ORLY) surged 14.4 percent to $260.3901 following upbeat Q1 profit.
    Concord Medical Services Holdings Limited (NYSE: CCM) gained 13.8 percent to $3.70.
    Penn National Gaming, Inc. (NASDAQ: PENN) rose 13.5 percent to $29.815 after reporting strong Q1 results.
    BioTelemetry, Inc. (NASDAQ: BEAT) rose 13.5 percent to $38.30 as the company reported stronger-than-expected earnings for its first quarter.
    Advanced Micro Devices, Inc. (NASDAQ: AMD) shares rose 13.1 percent to $10.985 as the company reported upbeat results for its first quarter.
    SJW Group (NYSE: SJW) shares gained 11.8 percent to $63.59 following Q1 results. California Water Service Group made an offer for SJW.
    Churchill Downs Incorporated (NASDAQ: CHDN) climbed 9.8 percent to $278.40 following Q1 results.
    CYS Investments, Inc. (NYSE: CYS)
  • [By Lisa Levin] Gainers
    Genprex, Inc. (NASDAQ: GNPX) shares gained 86.76 percent to close at $11.00 on Thursday.
    Comstock Resources, Inc. (NYSE: CRK) shares climbed 47.06 percent to close at $7.00 after the company disclosed a deal with Arkoma Drilling L.P. and Williston Drilling, L.P. to buy oil & gas properties in North Dakota. Comstock announced withdrawal of tender offers for outstanding secured notes.
    Ceridian HCM Holding Inc. (NASDAQ: CDAY) gained 41.86 percent to close at $31.21.
    MarineMax, Inc. (NYSE: HZO) shares rose 26.5 percent to close at $22.20 as the company posted upbeat Q2 results and raised its FY18 outlook.
    Concord Medical Services Holdings Limited (NYSE: CCM) jumped 24.92 percent to close at $4.06.
    Mattersight Corporation (NASDAQ: MATR) shares climbed 23.26 percent to close at $2.65 after the company agreed to be purchased by NICE Ltd.
    Chipotle Mexican Grill, Inc. (NYSE: CMG) rose 24.44 percent to close at $422.50 as the company reported stronger-than-expected results for its first quarter on Wednesday.
    Ultra Clean Holdings, Inc. (NASDAQ: UCTT) gained 17.75 percent to close at $18.64 following upbeat Q1 earnings.
    PCM, Inc. (NASDAQ: PCMI) rose 16.59 percent to close at $12.30 following Q1 results.
    Zymeworks Inc. (NASDAQ: ZYME) rose 16.06 percent to close at $15.25.
    Alexion Pharmaceuticals, Inc. (NASDAQ: ALXN) shares climbed 14.5 percent to close at $121.42 as the company posted reported Q1 beat And raised FY18 outlook.
    Advanced Micro Devices, Inc. (NASDAQ: AMD) shares gained 13.7 percent to close at $11.04 as the company reported upbeat results for its first quarter.
    Axsome Therapeutics, Inc. (NASDAQ: AXSM) rose 13.21 percent to close at $3.00 after the company disclosed a positive outcome of the interim analysis of STRIDE-1 Phase 3 trial of AXS-05 in treatment resistant depression.
    O'Reilly Automotive, Inc. (NASDAQ: ORLY) jumped 13.06 percent to close at $257.40 following upbeat Q1 profit.
    BioTelemetry,
  • [By Lisa Levin] Gainers
    Axsome Therapeutics, Inc. (NASDAQ: AXSM) rose 22.6 percent to $3.25 in pre-market trading after the company disclosed a positive outcome of the interim analysis of STRIDE-1 Phase 3 trial of AXS-05 in treatment resistant depression.
    Mattersight Corporation (NASDAQ: MATR) shares rose 23.2 percent to $2.65 in pre-market trading after the company agreed to be purchased by NICE Ltd.
    Comstock Resources, Inc. (NYSE: CRK) rose 21.2 percent to $5.77 in pre-market trading after the company disclosed a deal to buy oil & gas properties in North Dakota from Arkoma, Williston Drilling for about $620 million. The company also announced withdrawal of tender offers for outstanding secured notes.
    Chipotle Mexican Grill, Inc. (NYSE: CMG) rose 13.7 percent to $386.00 in pre-market trading as the company reported stronger-than-expected results for its first quarter on Wednesday.
    Quantenna Communications, Inc. (NASDAQ: QTNA) shares rose 12.6 percent to $14.70 in pre-market trading. Quantenna is expected to release Q1 results on April 30..
    BioTelemetry, Inc. (NASDAQ: BEAT) rose 11.1 percent to $37.50 in pre-market trading as the company reported stronger-than-expected earnings for its first quarter.
    Penn National Gaming, Inc. (NASDAQ: PENN) rose 10.4 percent to $29.00 in pre-market trading after reporting strong Q1 results.
    O'Reilly Automotive, Inc. (NASDAQ: ORLY) rose 9.8 percent to $250.00 in pre-market trading following upbeat Q1 profit.
    Advanced Micro Devices, Inc. (NASDAQ: AMD) shares rose 9.4 percent to $10.62 in pre-market trading as the company reported upbeat results for its first quarter.
    CYS Investments, Inc. (NYSE: CYS) rose 9.1 percent to $7.22 in pre-market trading after the company agreed to be acquired by Two Harbors Investment Corp (NYSE: TWO).
    GNC Holdings, Inc. (NYSE: GNC) rose 8.3 percent to $4.18 in pre-market trading after reporting Q1 results.
    Domino's Pizza, Inc. (NYSE: DPZ) shares rose 7.6 percent to $251.2
  • [By Joseph Griffin]

    Get a free copy of the Zacks research report on Axsome Therapeutics (AXSM)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Paul Ausick]

    Axsome Therapeutics Inc. (NASDAQ: AXSM) traded down about 43% Tuesday and posted a new 52-week low of $3.20 after closing Monday at $5.55. The 52-week high is $6.45. Volume was about 3.8 million, about 19 times the daily average of around 220,000 shares. The company will stop a “futile” portion of a trial of its treatment for knee osteoarthritis.

Best Clean Energy Stocks To Invest In Right Now: Sage Therapeutics, Inc.(SAGE)

Advisors’ Opinion:

  • [By Shane Hupp]

    SG Americas Securities LLC acquired a new position in SAGE Therapeutics Inc (NASDAQ:SAGE) in the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund acquired 5,233 shares of the biopharmaceutical company’s stock, valued at approximately $843,000.

  • [By Chris Lange]

    Buy-dip on several “Potential Blockbusters” Aimmune Therapeutics, Inc. (NASDAQ: AIMT), Audentes Therapeutics, Inc. (NASDAQ: BOLD), AveXis, Inc. (NASDAQ: AVXS), Bluebird Bio, Inc. (NASDAQ: BLUE), Esperion Therapeutics, Inc. (NASDAQ: ESPR), and Sage Therapeutics, Inc. (NASDAQ: SAGE) are buy-dip candidates given their bullish trends and favorable technical patterns. Intercept Pharmaceuticals, Inc. (NASDAQ: ICPT), Prothena Corp. PLC (NASDAQ: PRTA), Tesaro, Inc. (NASDAQ: TSRO) and Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) have bearish set-ups. Heron Therapeutics, Inc. (NASDAQ: HRTX) is bigger picture bullish, but may correct further on a move below $19.55. Clovis Oncology, Inc. (NASDAQ: CLVS) has bearish set-up and bulls need to push above $69 to invalidate.

  • [By Maxx Chatsko]

    After sliding 41.8% in 2018, shares of Sage Therapeutics (NASDAQ:SAGE) jumped nearly 49% last month, according to data from S&P Global Market Intelligence. The sudden leap came after the company reported impressive results for SAGE-217 in a phase 3 trial studying the drug candidate as a potential treatment for postpartum depression.

  • [By Joseph Griffin]

    Stevens Capital Management LP bought a new stake in shares of SAGE Therapeutics Inc (NASDAQ:SAGE) in the 2nd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund bought 3,223 shares of the biopharmaceutical company’s stock, valued at approximately $504,000.

  • [By ]

    Sage Therapeutics (SAGE) : “Let’s wait and see. I can’t bless it until I see more from them.”

    AbbVie (ABBV) : “I want to stay away from controversy. I like Eli Lilly (LLY) .”

  • [By Dan Caplinger]

    Friday was a poor day on Wall Street, as the Dow Jones Industrials fell 200 points and other major benchmarks lost about 1%. Rising bond yields were a major source of consternation among those following the financial markets, with the 10-year Treasury hitting 2.95% and helping to send mortgage rates sharply higher. Even though earnings season has gone fairly well for many companies, some investors are also starting to realize that political issues are likely to cloud the outlook for the U.S. economy in the coming months, creating more uncertainty that could stymie further market gains. Some bad news affecting individual companies also added to the negative mood. Stanley Black & Decker (NYSE:SWK), ManpowerGroup (NYSE:MAN), and Sage Therapeutics (NASDAQ:SAGE) were among the worst performers on the day. Here’s why they did so poorly.

Best Clean Energy Stocks To Invest In Right Now: Marsh & McLennan Companies, Inc.(MMC)

Advisors’ Opinion:

  • [By Max Byerly]

    Marsh & McLennan Companies (NYSE: MMC) and Kering (OTCMKTS:PPRUY) are both large-cap finance companies, but which is the superior investment? We will contrast the two companies based on the strength of their profitability, earnings, dividends, analyst recommendations, risk, valuation and institutional ownership.

  • [By Shane Hupp]

    Get a free copy of the Zacks research report on Marsh & McLennan Companies (MMC)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Shane Hupp]

    Enlightenment Research LLC acquired a new position in Marsh & McLennan Companies, Inc. (NYSE:MMC) during the 4th quarter, HoldingsChannel reports. The fund acquired 800 shares of the financial services provider’s stock, valued at approximately $64,000.

  • [By Shane Hupp]

    Marsh & McLennan Companies (NYSE:MMC) had its price target reduced by equities research analysts at Citigroup from $100.00 to $98.00 in a note issued to investors on Thursday. The firm presently has a “buy” rating on the financial services provider’s stock. Citigroup’s price objective would suggest a potential upside of 15.01% from the company’s previous close.

  • [By Logan Wallace]

    Marsh & McLennan Companies, Inc. (NYSE:MMC) has received an average recommendation of “Hold” from the eleven brokerages that are currently covering the firm, Marketbeat reports. One investment analyst has rated the stock with a sell rating, five have given a hold rating and five have assigned a buy rating to the company. The average twelve-month target price among brokerages that have updated their coverage on the stock in the last year is $91.86.

Best Clean Energy Stocks To Invest In Right Now: MetLife, Inc.(MET)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Here are some of the news headlines that may have impacted Accern Sentiment’s analysis:

    Get MetLife alerts:

    Ultimate Stock-Pickers: Top 10 Buys and Sells (finance.yahoo.com) MetLife: Why investors should pay close attention to the… (finance.yahoo.com) Goldman Sachs Group Lowers MetLife (MET) to Neutral (americanbankingnews.com) Review: Morgan Wallen rocks MetLife Stadium, opens for Luke Bryan (digitaljournal.com) Goldman Sachs Downgrades MetLife (MET) to Neutral (streetinsider.com)

    Several equities research analysts recently issued reports on MET shares. Zacks Investment Research downgraded shares of MetLife from a “hold” rating to a “sell” rating in a research note on Tuesday, March 20th. Bank of America started coverage on shares of MetLife in a research note on Monday, March 26th. They set a “neutral” rating and a $50.00 price target on the stock. Atlantic Securities raised shares of MetLife from a “neutral” rating to an “overweight” rating in a research note on Monday, March 26th. Wells Fargo & Co reaffirmed a “buy” rating and set a $60.00 price target on shares of MetLife in a research note on Thursday, March 1st. Finally, Morgan Stanley dropped their price target on shares of MetLife from $58.00 to $56.00 and set an “equal weight” rating on the stock in a research note on Thursday, April 5th. Two investment analysts have rated the stock with a sell rating, ten have assigned a hold rating and nine have issued a buy rating to the company’s stock. The company currently has an average rating of “Hold” and an average target price of $56.81.

  • [By Lisa Levin] Gainers
    Cara Therapeutics, Inc. (NASDAQ: CARA) rose 18.2 percent to $13.71 in pre-market trading. Cara Therapeutics and Vifor Fresenius Medical Care Renal Pharma entered into ex-U.S. licensing agreement to commercialize KORSUVA™ injection in dialysis patients with pruritus.
    Heat Biologics, Inc. (NASDAQ: HTBX) shares rose 10.6 percent to $2.20 in pre-market trading after surging 12.43 percent on Tuesday.
    VAALCO Energy, Inc. (NYSE: EGY) rose 10.5 percent to $2.37 in pre-market trading after dropping 10.04 percent on Tuesday.
    Boxlight Corporation (NASDAQ: BOXL) rose 8.3 percent to $7.15 in pre-market trading after falling 16.03 percent on Tuesday.
    Tiffany & Co. (NYSE: TIF) rose 7.8 percent to $110.25 in pre-market trading after the company reported upbeat results for its first quarter and raised its FY2018 earnings guidance.
    Heat Biologics, Inc. (NASDAQ: HTBX) shares rose 7.1 percent to $2.13 in pre-market trading. after climbing 12.43 percent on Tuesday.
    Clementia Pharmaceuticals Inc. (NASDAQ: CMTA) rose 5.9 percent to $20.01 in pre-market trading after reporting positive Phase 2 Part B data showing treatment with palovarotene significantly reduces new bone growth in patients with FOP.
    Under Armour, Inc. (NYSE: UA) rose 3.5 percent to $18.44 in pre-market trading.
    Aegean Marine Petroleum Network Inc. (NYSE: ANW) shares rose 3.5 percent to $2.95 in pre-market trading.
    MetLife, Inc. (NYSE: MET) rose 3.2 percent to $50.00 in pre-market trading after reporting a $1.5 billion buyback plan.
    Lowe's Companies, Inc. (NYSE: LOW) rose 3.2 percent to $88.51 in pre-market trading. Lowe's reported downbeat results for its first quarter on Wednesday.

    Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.

  • [By Shane Hupp]

    Salem Investment Counselors Inc. lifted its holdings in Metlife Inc (NYSE:MET) by 5.1% during the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 42,080 shares of the financial services provider’s stock after buying an additional 2,050 shares during the period. Salem Investment Counselors Inc.’s holdings in Metlife were worth $1,835,000 as of its most recent filing with the Securities and Exchange Commission.

  • [By Max Byerly]

    Brookstone Capital Management reduced its stake in shares of Metlife Inc (NYSE:MET) by 3.1% during the 2nd quarter, according to its most recent filing with the SEC. The firm owned 108,058 shares of the financial services provider’s stock after selling 3,447 shares during the period. Brookstone Capital Management’s holdings in Metlife were worth $4,711,000 at the end of the most recent quarter.

  • [By Logan Wallace]

    State Treasurer State of Michigan lessened its stake in shares of MetLife (NYSE:MET) by 1.1% in the 1st quarter, according to its most recent disclosure with the SEC. The firm owned 305,185 shares of the financial services provider’s stock after selling 3,300 shares during the period. State Treasurer State of Michigan’s holdings in MetLife were worth $14,005,000 as of its most recent SEC filing.

  • [By Ethan Ryder]

    Putnam Investments LLC increased its position in shares of Metlife Inc (NYSE:MET) by 1,847.7% in the 2nd quarter, according to the company in its most recent disclosure with the SEC. The fund owned 523,396 shares of the financial services provider’s stock after purchasing an additional 496,523 shares during the quarter. Putnam Investments LLC owned 0.05% of Metlife worth $22,820,000 as of its most recent filing with the SEC.

Top 5 Performing Stocks To Own For 2018

Bank of America’s (NYSE:BAC) shares suddenly dropped last week, slumping ~6 percent on Tuesday as investors rushed to sell financials and take profits in stocks that have soared since the U.S. election. Republicans also don’t appear to be able to score legislative victories as easily as investors thought, which raises concerns over the sustainability of the Trump rally.

Let’s first agree that Bank of America has been a very good investment already in the last several months, but especially over the last year. Believe it or not, but an investment in Bank of America has returned ~70 percent since March 28, 2016, outperforming other financial stocks as well as major stock market indices by a wide margin.

Top 5 Performing Stocks To Own For 2018: Dave & Buster's Entertainment, Inc.(PLAY)

Advisors’ Opinion:

  • [By Peter Graham]

    Small cap restaurant and entertainment stockDave & Busters Entertainment Inc (NASDAQ: PLAY)updated guidance for its fiscal 2017 (which ends on February 4, 2018):

  • [By Stephan Byrd]

    Equities analysts expect Dave & Buster’s (NASDAQ:PLAY) to report $324.81 million in sales for the current fiscal quarter, according to Zacks. Six analysts have issued estimates for Dave & Buster’s’ earnings, with estimates ranging from $320.19 million to $332.00 million. Dave & Buster’s posted sales of $304.15 million during the same quarter last year, which suggests a positive year over year growth rate of 6.8%. The firm is scheduled to report its next quarterly earnings report on Tuesday, June 5th.

  • [By Trey Thoelcke]

    Dave & Buster’s Entertainment Inc.’s (NASDAQ: PLAY) fiscal fourth-quarter report is scheduled for Tuesday after the markets close. The consensus estimates are $0.60 in earnings per share (EPS) on $305.49 million in revenue. The shares ended the week at $41.74. The consensus price target is $65.33, and the 52-week trading range is $41.04 to $73.48.

  • [By Matt Hogan]

    Casual-dining chains have not been winners during this economic expansion. Millenials, with their need for more social media-worthy experiences, have been blamed for the decline in conjunction with Baby Boomers moving onto fixed incomes as they retire.

    Dave & Buster's Entertainment Inc (NASDAQ: PLAY) provides an eat, drink, play, and watch experience for consumers. This hybrid entertainment/dining experience has fared well since going public in 2012, attracting higher-income adults in the 21-39 age range.
    Poor same-store sales last quarter knocked the premium off the stock price, but top and bottom-line growth were still strong. Margins and efficiency ratios top its competitors, and Wall Street and quant valuation models agree that there is a strong upside for this diamond in the casual-dining rough.

    You'll Probably Want to Sit Down for This

    Casual dining, the traditional sit-down, full-service restaurant experience is getting hit by demographics. Millennials want hip, social-media worthy experiences and retiring Baby Boomers are thrifty on their fixed incomes. Headlines such as "Millennials Are Killing Chains Like Buffalo Wild Wings And Applebee's" are not uncommon.

Top 5 Performing Stocks To Own For 2018: Sage Therapeutics, Inc.(SAGE)

Advisors’ Opinion:

  • [By Dan Caplinger]

    Friday was a poor day on Wall Street, as the Dow Jones Industrials fell 200 points and other major benchmarks lost about 1%. Rising bond yields were a major source of consternation among those following the financial markets, with the 10-year Treasury hitting 2.95% and helping to send mortgage rates sharply higher. Even though earnings season has gone fairly well for many companies, some investors are also starting to realize that political issues are likely to cloud the outlook for the U.S. economy in the coming months, creating more uncertainty that could stymie further market gains. Some bad news affecting individual companies also added to the negative mood. Stanley Black & Decker (NYSE:SWK), ManpowerGroup (NYSE:MAN), and Sage Therapeutics (NASDAQ:SAGE) were among the worst performers on the day. Here’s why they did so poorly.

  • [By Chris Lange]

    Buy-dip on several “Potential Blockbusters” Aimmune Therapeutics, Inc. (NASDAQ: AIMT), Audentes Therapeutics, Inc. (NASDAQ: BOLD), AveXis, Inc. (NASDAQ: AVXS), Bluebird Bio, Inc. (NASDAQ: BLUE), Esperion Therapeutics, Inc. (NASDAQ: ESPR), and Sage Therapeutics, Inc. (NASDAQ: SAGE) are buy-dip candidates given their bullish trends and favorable technical patterns. Intercept Pharmaceuticals, Inc. (NASDAQ: ICPT), Prothena Corp. PLC (NASDAQ: PRTA), Tesaro, Inc. (NASDAQ: TSRO) and Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) have bearish set-ups. Heron Therapeutics, Inc. (NASDAQ: HRTX) is bigger picture bullish, but may correct further on a move below $19.55. Clovis Oncology, Inc. (NASDAQ: CLVS) has bearish set-up and bulls need to push above $69 to invalidate.

  • [By ]

    Cramer was bearish on Geron (GERN) , Mitek Systems (MITK) , AK Steel Holding (AKS) , Sage Therapeutics (SAGE) and AbbVie (ABBV) .

    Search Jim Cramer’s “Mad Money” trading recommendations using our exclusive “Mad Money” Stock Screener.

Top 5 Performing Stocks To Own For 2018: ZIOPHARM Oncology Inc(ZIOP)

Advisors’ Opinion:

  • [By Paul Ausick]

    Ziopharm Oncology Inc. (NASDAQ: ZIOP) dropped more than 10% Tuesday to post a 52-week low of $3.77 after closing at $4.20 on Monday. The 52-week high is $7.88. Volume was around 3.7 million, more than double the daily average. The company reported Tuesday on progress of two platforms it is developing and investors did not like what they heard.

  • [By Todd Campbell]

    It garnered a lot of attention in 2015 when Ziopharm (NASDAQ:ZIOP) announced it would use its “sleeping beauty” technology to improve upon chimeric antigen receptor T-cell therapies that it was developing. Then, its mosquitoes that are engineered so that they can’t reproduce and spread disease won investor interest during the Zika virus outbreak in 2015 and 2016.

  • [By Keith Speights]

    Over the last 12 months, bluebird bio (NASDAQ:BLUE) stock has more than doubled. During the same period, Ziopharm Oncology’s (NASDAQ:ZIOP) share price has tumbled over 30%. That’s the past, though. Which of these two clinical-stage biotech stocks is the better pick for investors now?

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on Ziopharm Oncology (ZIOP)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Lisa Levin]

    Check out these big penny stock gainers and losers

    Losers
    Stellar Biotechnologies, Inc. (NASDAQ: SBOT) fell 42 percent to $2.25 in pre-market trading after dropping 31.45 percent on Thursday. Stellar Biotechnologies priced 2.075 million units at price of $2.65 per unit.
    Symantec Corporation (NASDAQ: SYMC) shares fell 25.2 percent to $21.82 in pre-market trading. Symantec reported better-than-expected earnings for its fourth quarter, but issued weak second-quarter guidance.
    AGM Group Holdings Inc. (NASDAQ: AGMH) shares fell 9.5 percent to $10 in pre-market trading after surging 7.79 percent on Thursday.
    ZIOPHARM Oncology, Inc. (NASDAQ: ZIOP) fell 8.9 percent to $4.11 in pre-market trading after the company posted wider-than-expected Q1 loss.
    Redfin Corporation (NASDAQ: RDFN) fell 8.6 percent to $21.00 in pre-market trading after reporting Q1 results.
    Geron Corporation (NASDAQ: GERN) fell 8.3 percent to $3.33 in pre-market trading. Geron posted a Q1 loss of $0.04 per share.
    Talend S.A. (NASDAQ: TLND) shares fell 6 percent to $56 in pre-market trading after reporting Q1 results.
    Flotek Industries, Inc. (NYSE: FTK) fell 5.4 percent to $3.54 in pre-market trading after dropping 2.35 percent on Thursday.
    Halozyme Therapeutics, Inc. (NASDAQ: HALO) fell 5.1 percent to $18.95 in pre-market trading after reporting Q1 results.
    Yelp Inc. (NYSE: YELP) shares fell 4.9 percent to $45.40 in pre-market trading. Yelp reported stronger-than-expected results for its first quarter on Thursday.
    Aldeyra Therapeutics, Inc. (NASDAQ: ALDX) shares fell 3.3 percent to $7.50 in pre-market trading after dropping 4.32 percent on Thursday

Top 5 Performing Stocks To Own For 2018: NF Energy Saving Corporation(NFEC)

Advisors’ Opinion:

  • [By Lisa Levin] Gainers
    Blink Charging Co. (NASDAQ: BLNK) shares jumped 26.5 percent to $6.9042. Blink Charging reported Q1 net income of $2.2 million, versus a year-ago net loss of $3.1 million.
    Eleven Biotherapeutics, Inc. (NASDAQ: EBIO) shares climbed 17.4 percent to $3.11. Eleven Biotherapeutics posted a Q1 loss of $0.11 per share.
    Flanigan's Enterprises, Inc. (NYSE: BDL) shares jumped 17 percent to $27.97 following Q2 results. Flanigan's Enterprises posted Q2 earnings of $0.75 per share on sales of $29.456 million.
    Borqs Technologies, Inc. (NASDAQ: BRQS) rose 15.8 percent to $8.05 after reporting Q1 results.
    Abaxis, Inc. (NASDAQ: ABAX) jumped 15.3 percent to $82.75. Zoetis Inc. (NYSE: ZTS) announced plans to acquire Abaxis for $83 per share in cash.
    21Vianet Group, Inc. (NASDAQ: VNET) gained 15.1 percent to $6.33.
    Gemphire Therapeutics Inc. (NASDAQ: GEMP) rose 13.8 percent to $6.27.
    Enphase Energy, Inc. (NASDAQ: ENPH) gained 12.8 percent to $5.98. H.C. Wainwright initiated coverage on Enphase Energy with a Buy rating.
    PetIQ Inc (NASDAQ: PETQ) shares surged 12.1 percent to $21.68 after reporting a first-quarter sales beat.
    NF Energy Saving Corporation (NASDAQ: NFEC) climbed 11.6 percent to $2.399.
    Allied Healthcare Products, Inc. (NASDAQ: AHPI) surged 11.4 percent to $3.0643.
    Boot Barn Holdings, Inc. (NYSE: BOOT) gained 11.1 percent to $24.40 after the company reported upbeat results for its fourth quarter and issued strong first-quarter earnings guidance.
    Ascena Retail Group, Inc. (NASDAQ: ASNA) rose 10.9 percent to $3.16.
    Sea Limited (NYSE: SE) gained 10.1 percent to $11.71 after reporting Q1 results.
    GEE Group, Inc. (NYSE: JOB) climbed 7.9 percent to $2.61 following Q2 results.
    The ONE Group Hospitality, Inc. (NASDAQ: STKS) gained 7.6 percent to $2.41 after reporting Q1 results.
    Biolinerx Ltd/S ADR (NASDAQ: BLRX) rose 7.3 percent to $0.8798 after the company was granted a patent approval. The clinical-st

Top 5 Performing Stocks To Own For 2018: China Petroleum & Chemical Corporation(SNP)

Advisors’ Opinion:

  • [By Max Byerly]

    News headlines about Sinopec (NYSE:SNP) have been trending somewhat positive on Saturday, Accern reports. Accern identifies positive and negative media coverage by reviewing more than twenty million news and blog sources in real time. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Sinopec earned a coverage optimism score of 0.23 on Accern’s scale. Accern also gave headlines about the oil and gas company an impact score of 45.9265677546286 out of 100, indicating that recent media coverage is somewhat unlikely to have an effect on the stock’s share price in the near term.

  • [By Joseph Griffin]

    Sinopec (NYSE:SNP) announced a Semi-Annual dividend on Wednesday, March 28th, Zacks reports. Investors of record on Friday, May 25th will be paid a dividend of 4.568 per share by the oil and gas company on Thursday, June 21st. The ex-dividend date is Thursday, May 24th.

Top 5 Medical Stocks To Watch For 2018

&l;p&g;&l;img class=&q;dam-image getty size-large wp-image-612287558&q; src=&q;https://specials-images.forbesimg.com/dam/imageserve/612287558/960×0.jpg?fit=scale&q; data-height=&q;640&q; data-width=&q;960&q;&g; PUEBLO, CO – September 3, 2016: A truck rushes past the LSF farm in Pueblo County, one of the only places in Colorado that allows for commercial cannabis grows outdoors, like the marijuana farm Los Sue&a;ntilde;os Farms LLC. LSF owns 36 acres of rich farmland in Pueblo County, Colorado, which it leases to four Colorado licensed retail marijuana cultivations: Farmboy LLC, Baseball 18 LLC, Los Sue&a;ntilde;os LLC and Emerald Fields Grow LLC. (Photo by Vince Chandler / The Denver Post)

On Jan. 1, 2018, the US&s;s largest and most populated state &a;mdash; California &a;mdash; oversaw the legalization of&a;nbsp;recreational marijuana. Though not the first state to do this, California&s;s action is a milestone for the cannabis industry, and for American drug legislation in general.&a;nbsp;Almost as, if not equally, important is the fact that&a;nbsp;marijuana&s;s recreational legality comes with major taxes: a 15% statewide tax on all&a;nbsp;recreational and medical cannabis products, and additional local taxes and fees.

Top 5 Medical Stocks To Watch For 2018: Armstrong World Industries Inc(AWI)

Advisors’ Opinion:

  • [By Ethan Ryder]

    AptarGroup (NYSE: ATR) and Armstrong World Industries (NYSE:AWI) are both mid-cap industrial products companies, but which is the better stock? We will contrast the two companies based on the strength of their valuation, risk, dividends, analyst recommendations, earnings, institutional ownership and profitability.

Top 5 Medical Stocks To Watch For 2018: Sage Therapeutics, Inc.(SAGE)

Advisors’ Opinion:

  • [By ]

    Sage Therapeutics (SAGE) : “Let’s wait and see. I can’t bless it until I see more from them.”

    AbbVie (ABBV) : “I want to stay away from controversy. I like Eli Lilly (LLY) .”

  • [By Chris Lange]

    Buy-dip on several “Potential Blockbusters” Aimmune Therapeutics, Inc. (NASDAQ: AIMT), Audentes Therapeutics, Inc. (NASDAQ: BOLD), AveXis, Inc. (NASDAQ: AVXS), Bluebird Bio, Inc. (NASDAQ: BLUE), Esperion Therapeutics, Inc. (NASDAQ: ESPR), and Sage Therapeutics, Inc. (NASDAQ: SAGE) are buy-dip candidates given their bullish trends and favorable technical patterns. Intercept Pharmaceuticals, Inc. (NASDAQ: ICPT), Prothena Corp. PLC (NASDAQ: PRTA), Tesaro, Inc. (NASDAQ: TSRO) and Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) have bearish set-ups. Heron Therapeutics, Inc. (NASDAQ: HRTX) is bigger picture bullish, but may correct further on a move below $19.55. Clovis Oncology, Inc. (NASDAQ: CLVS) has bearish set-up and bulls need to push above $69 to invalidate.

  • [By ]

    Cramer was bearish on Geron (GERN) , Mitek Systems (MITK) , AK Steel Holding (AKS) , Sage Therapeutics (SAGE) and AbbVie (ABBV) .

    Search Jim Cramer’s “Mad Money” trading recommendations using our exclusive “Mad Money” Stock Screener.

Top 5 Medical Stocks To Watch For 2018: Amedisys Inc(AMED)

Advisors’ Opinion:

  • [By Logan Wallace]

    Get a free copy of the Zacks research report on Amedisys Home Health and Hospice Care (AMED)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Lisa Levin]

     

    Companies Reporting After The Bell
    Hertz Global Holdings, Inc. (NYSE: HTZ) is projected to post quarterly loss at $1.31 per share on revenue of $1.97 billion.
    International Flavors & Fragrances Inc. (NYSE: IFF) is estimated to post quarterly earnings at $1.59 per share on revenue of $909.36 million.
    Zillow Group, Inc. (NASDAQ: ZG) is expected to post quarterly earnings at $0.06 per share on revenue of $294.79 million.
    General Cable Corporation (NYSE: BGC) is estimated to post quarterly earnings at $0.15 per share on revenue of $980.61 million.
    Central Garden & Pet Company (NASDAQ: CENT) is expected to post quarterly earnings at $0.84 per share on revenue of $598.45 million.
    Cabot Corporation (NYSE: CBT) is estimated to post quarterly earnings at $1 per share on revenue of $746.42 million.
    Fabrinet (NYSE: FN) is expected to post quarterly earnings at $0.71 per share on revenue of $319.71 million.
    National General Holdings Corp. (NASDAQ: NGHC) is projected to post quarterly earnings at $0.55 per share on revenue of $1.08 billion.
    The Navigators Group, Inc. (NASDAQ: NAVG) is estimated to post quarterly earnings at $0.75 per share on revenue of $320.92 million.
    Diplomat Pharmacy, Inc. (NYSE: DPLO) is expected to post quarterly earnings at $0.22 per share on revenue of $1.29 billion.
    Trex Company, Inc. (NYSE: TREX) is projected to post quarterly earnings at $1.19 per share on revenue of $172.22 million.
    AMC Entertainment Holdings, Inc. (NYSE: AMC) is expected to post quarterly earnings at $0.09 per share on revenue of $1.35 billion.
    Envision Healthcare Corporation (NYSE: EVHC) is projected to post quarterly earnings at $0.64 per share on revenue of $2.02 billion.
    Regal Beloit Corporation (NYSE: RBC) is estimated to post quarterly earnings at $1.23 per share on revenue of $869.64 million.
    Amedisys, Inc. (NASDAQ: AMED) is projected to post quarterly earnings at $0.67 per share on revenue of $39

  • [By Stephan Byrd]

    Amedisys Home Health and Hospice Care (NASDAQ:AMED) had its target price lifted by Robert W. Baird to $66.00 in a report issued on Tuesday. They currently have a neutral rating on the health services provider’s stock.

Top 5 Medical Stocks To Watch For 2018: Flextronics International Ltd.(FLEX)

Advisors’ Opinion:

  • [By Max Byerly]

    Get a free copy of the Zacks research report on Flex (FLEX)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Peter Graham]

    Mid cap electronic manufacturing services (EMS) stock Flextronics International Ltd (NASDAQ: FLEX) reported fiscal Q3 2017 earnings after the market closed on Thursday with results beating expectations. Q3 net sales grew 10% to$6.75 billion above the high end of the guidance range of $6.3 to $6.7 billion. GAAP net income was approximately $118 millionversus net income of $129 million.The earnings release also noted:

  • [By Lisa Levin]

    Check out these big penny stock gainers and losers

    Losers
    World Fuel Services Corporation (NYSE: INT) tumbled 18 percent to $22.90 following Q1 results.
    Biglari Holdings Inc. (NYSE: BH) fell 17.4 percent to $349.52. Washington Prime Group will replace Biglari Holdings in the S&P SmallCap 600 on Tuesday, May 1.
    Flex Ltd. (NASDAQ: FLEX) dipped 15.7 percent to $14.03 after a mixed fourth quarter report.
    FormFactor, Inc. (NASDAQ: FORM) fell 15.3 percent to $11.65. FormFactor is expected to release Q1 results on May 2.
    Data I/O Corporation (NASDAQ: DAIO) dropped 14.3 percent to $6.24 following Q1 results.
    National Instruments Corporation (NASDAQ: NATI) fell 14.3 percent to $ 42.34 after reporting Q1 results.
    United States Steel Corporation (NYSE: X) dipped 14.2 percent to $32.37 following Q1 results.
    Civeo Corporation (NYSE: CVEO) dropped 13.5 percent to $3.33. Civeo posted a Q1 loss of $0.42 per share on sales of $101.504 million.
    athenahealth, Inc. (NASDAQ: ATHN) fell 12.4 percent to $125.310 after reporting Q1 results.
    Charter Communications, Inc. (NASDAQ: CHTR) shares tumbled 12.1 percent to $262.06 as the company posted Q1 results.
    Value Line, Inc. (NASDAQ: VALU) fell 11.3 percent to $19.10.
    Federated Investors, Inc. (NYSE: FII) shares dropped 11.2 percent to $27.605 after the company posted downbeat quarterly earnings.
    AV Homes, Inc. (NASDAQ: AVHI) declined 10.7 percent to $17.20 following Q1 results.
    CalAmp Corp. (NASDAQ: CAMP) dropped 9.4 percent to $21.01 after reporting Q4 results.
    Tandem Diabetes Care, Inc. (NASDAQ: TNDM) shares fell 8.9 percent to $7.280 following mixed Q1 results.
    Sony Corporation (NYSE: SNE) shares fell 8.4 percent to $45.97 after reporting Q4 results.
    LogMeIn Inc (NASDAQ: LOGM) fell 8.2 percent to $109.825. LogMeIn reported upbeat earnings for its first quarter, but issued weak second quarter and FY18 earning guidance.
    Eleven Biotherapeutics, Inc. (NASDAQ: EBIO

  • [By Timothy Green]

    Shares of manufacturing services provider Flex Ltd. (NASDAQ:FLEX) slumped on Friday after the company reported mixed fourth-quarter results and provided earnings guidance that fell short of analyst expectations. As of 11:15 a.m. EDT, the stock was down about 16%.

Top 5 Medical Stocks To Watch For 2018: Ctrip.com International, Ltd.(CTRP)

Advisors’ Opinion:

  • [By Logan Wallace]

    Here are some of the media headlines that may have impacted Accern Sentiment’s rankings:

    Get Ctrip alerts:

    Let Analyse Simple Moving Averages Ctrip.com International Ltd (NASDAQ: CTRP) (stockspen.com) Ctrip.com International, Ltd. (CTRP) year to date performance remained at -3.24% (nasdaqfortune.com) Ctrip opens Oasis Lab, welcomes external startups to incubation program (tnooz.com) Ctrip.com International, Ltd. to Report First Quarter 2018 Financial Results on May 22, 2018 US Time (prnewswire.com) Ctrip.com International, Ltd. to Report First Quarter 2018 Financial Results on May 22, 2018 U.S. Time (finance.yahoo.com)

    Several research analysts have weighed in on the stock. BidaskClub cut shares of Ctrip from a “sell” rating to a “strong sell” rating in a report on Thursday, January 25th. TheStreet raised shares of Ctrip from a “c+” rating to a “b-” rating in a report on Monday, March 12th. Deutsche Bank assumed coverage on shares of Ctrip in a report on Monday, February 5th. They issued a “hold” rating and a $50.00 price target on the stock. TH Capital cut shares of Ctrip from a “buy” rating to a “hold” rating in a report on Monday, February 26th. Finally, Wells Fargo assumed coverage on shares of Ctrip in a report on Tuesday, January 30th. They issued a “market perform” rating and a $50.00 price target on the stock. One analyst has rated the stock with a sell rating, nine have issued a hold rating and nine have issued a buy rating to the company. The stock presently has an average rating of “Hold” and an average price target of $54.79.

  • [By Garrett Baldwin]

    While that is happening in the Middle East, trouble is brewing in Washington. In addition to reports that a Russian Oligarch paid Trump’s lawyer $500,000, a U.S. telecom giant is now caught up with the same lawyer. AT&T Corporation (NYSE: T) confirmed Tuesday night that it paid Trump lawyer Michael Cohen for information on the administration. AT&T stock is up 0.6% in premarket hours.
    Four Stocks to Watch Today: TRIP, MTCH, FOXA, DIS
    Shares of TripAdvisor (Nasdaq: TRIP) popped nearly 20% after the company crushed earnings after the bell. In addition, the CFO Ernst Teunissen projected strong guidance for the rest of the year. The firm reported EPS of $0.30 on top of $378.0 million in revenue. Wall Street expected $0.16 per share on $360.84 million in revenue.
    Shares of Match Group (Nasdaq: MTCH) popped 3% after the company reported earnings after the bell. The dating site operator reported stronger than expected earnings and revenue figures on Tuesday. Overall, revenue jumped 36% compared to the same period in 2017. The firm also reported stronger than expected guidance. Of course, all anyone is talking about how Facebook Inc. (Nasdaq: FB) could impact the dating industry with its new plugin.
    Shares of 21st Century Fox (NYSE FOXA) are in focus as the firm prepares to report earnings before the bell. However, investors are more likely focused today on the expected bidding war between the Walt Disney Co. (NYSE: DIS) and Comcast Corporation (Nasdaq: CMCSA) to purchase key assets of the company. Fox is also tied up in a bidding war with Comcast to purchase British television provider Sky (OTC MKTS: SKYAY).
    Look for additional earnings reports from Booking Holdings (Nasdaq: BKNG), com International (Nasdaq: CTRP), Sina Corp. (Nasdaq: SINA), Albermarle Corp. (NYSE: ALB), Mylan Inc. (NYSE: MYL), SolarEdge Technologies (Nasdaq: SEDG), Wolverine World Wide (NYSE: WWW), IAC Interactive Corp. (NYSE: IAC), and Cavium Inc. (Nasdaq: CAVM).

    Eight Seconds

  • [By Lisa Levin] Gainers
    Gramercy Property Trust (NYSE: GPT) rose 13.4 percent to $27.01 in pre-market trading after the company agreed to be acquired by Blackstone Group L.P. (NYSE: BX) for $27.50 per share.
    Warrior Met Coal, Inc. (NYSE: HCC) rose 9.1 percent to $30 in pre-market trading after climbing 5.61 percent on Friday.
    Check-Cap Ltd. (NASDAQ: CHEK) rose 6.2 percent to $4.83 in pre-market trading after falling 48.35 percent on Friday.
    Ceragon Networks Ltd. (NASDAQ: CRNT) rose 6 percent to $2.85 in pre-market trading after climbing 1.89 percent on Friday.
    Ctrip.com International, Ltd. (NASDAQ: CTRP) rose 4.8 percent to $43.15 in pre-market trading.
    G1 Therapeutics, Inc. (NASDAQ: GTHX) rose 3.2 percent to $44.00 in pre-market trading after climbing 6.92 percent on Friday.
    Synchrony Financial (NYSE: SYF) rose 3.2 percent to $33.68 in pre-market trading after gaining 2.03 percent on Friday.
    Starbucks Corporation (NASDAQ: SBUX) rose 3.1 percent to $59.45 in pre-market trading. Nestle announced plans to acquire rights to market, sell and distribute Starbucks Brands.

    Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.

  • [By Paul Ausick]

    Ctrip.com International Ltd. (Nasdaq: CTRP) traded down about 3.5% Monday and posted a new 52-week low of $42.36 after closing Friday at $43.91. The stock’s 52-week high is $60.65. Volume totaled around 4.8 million, about equal to the daily average. The company had no specific news.

Top 10 Bank Stocks To Watch Right Now

The Federal Reserve raised its target of the federal-funds rate, the interest rate banks charge each other for overnight loans, by a quarter point to a range of 0.75% to 1%, and thats great news for Warren Buffetts Berkshire Hathaway (BRK.B) and its shareholders. As a bondholder, owner of insurance companies and an investor in big banks, Berkshire profits from rising interest rates in a number of ways, says David Kass, a professor at the University of Maryland’s Robert H. Smith School of Business who studies Buffett and is a Berkshire investor.

See Also: 6 Stocks That Stand to Gain From Fed Rate Hikes

“Since Berkshire currently has about $85 billion in cash invested primarily in short-term Treasuries, a [one percentage point] increase in short-term interest rates results in an additional income of $850 million per year for Berkshire,” Kass says. “Furthermore, Wells Fargo, one of Berkshire’s largest equity investments, will benefit from an increase in earnings as interest rates rise.

Top 10 Bank Stocks To Watch Right Now: L Brands, Inc.(LB)

Advisors’ Opinion:

  • [By Elizabeth Balboa]

    As tech falls, the once-forsaken shares of Gap Inc (NYSE: GPS), Macy’s Inc (NYSE: M), L Brands Inc (NYSE: LB), Costco Wholesale Corporation (NASDAQ: COST) and AT&T Inc. (NYSE: T) are surging.

  • [By WWW.THESTREET.COM]

    The next market worry is retail, with shares of Macy’s (M) falling over 14%, Kohl’s (KSS) down 19% and L Brands (LB) sinking more than 7%. 

    Cramer said the good news is that money is not leaving the stock market, it’s simply moving from the new winners back to the old winners, stocks like Facebook (FB) and Apple (AAPL) , two Action Alerts PLUS holdings.

  • [By Benzinga News Desk]

    In the parched terrain just south of the United States border, the prices of food and other necessities follow the dollar, whose value has been climbing: Link

    ECONOMIC DATA
    Industrial Production (MoM) for Feb 0.00% vs 0.20% consensus estimate; Manufacturing Outputs (MoM) for Feb 0.50% vs 0.40% consensus estimate.
    The University of Michigan's consumer sentiment index for March is schedule for release at 10:00 a.m. ET.
    The index of leading economic indicators for February will be released at 10:00 a.m. ET.
    The Baker Hughes North American rig count report for the latest week is schedule for release at 1:00 p.m. ET.
    ANALYST RATINGS
    Wunderlich upgraded Adobe Systems (NASDAQ: ADBE) from Hold to Buy
    FBR Capital upgraded L Brands (NYSE: LB) from Market Perform to Outperform
    Morgan Stanley upgraded Dean Foods (NYSE: DF) from Neutral to Overweight
    Baird downgraded Patheon (NYSE: PTHN) from Outperform to Neutral
    Citigroup downgraded SeaWorld Entertainment Inc (NYSE: SEAS) from Neutral to Sell
    Goldman Sachs downgraded Macerich (NYSE: MAC) from Neutral to Sell

    This is a tool used by the Benzinga News Desk each trading day — it's a look at everything happening in the market, in five minutes. To get the full version of this note every morning, click here or email minutes@benzinga.com.

  • [By Teresa Rivas]

    L Brands (LB) ended at the bottom of the S&P 500 on Thursday, after disappointing guidance overshadowed better-than-expected earnings.

    L Brands slid $9.19, or 15.8%, to $48.94, its lowest close since 2013. By contrast, the S&P 500 gained 0.99 points, or 0.04%, today to 2363.81.

    Oppenheimers Anna Andreeva and Samantha Lanman reiterated an Outperform rating and $75 price target on the stock, but admit that the magnitude of L Brands downward forecast was disappointing, even with weak industry trends signaled by peers like Wal-Mart (WMT), Macys (M), and TJX Cos. (TJX).

    While they still are bullish, they admit that the bottom isnt clear:

    In the last 5 years, LB’s multiple averaged in high-teens given quality of brands/management, with 13-14x trough not seen since early ’13valuation could still compress assuming guidance isn’t conservative enough. Sticking with Outperform for now, albeit near-term visibility is worsening.

    L Brands is down 25% this year.

Top 10 Bank Stocks To Watch Right Now: Greenhill & Co., Inc.(GHL)

Advisors’ Opinion:

  • [By Jim Robertson]

    For investors with a long memory, the Iridium communications service was launched on November 1, 1998 only for the founding company to go into Chapter 11 bankruptcy nine months later as the cost of service was prohibitive for many users. Iridium Satellite LLC was eventually merged with a special purpose acquisition company (GHQ) created by the investment bank Greenhill & Co. (NYSE: GHL) in September 2009 to form Iridium Communications.

  • [By Lisa Levin]

    In trading on Friday, financial shares slipped by 0.55 percent. Meanwhile, top losers in the sector included Greenhill & Co., Inc. (NYSE: GHL), down 11 percent, and SVB Financial Group (NASDAQ: SIVB), down 8 percent.

Top 10 Bank Stocks To Watch Right Now: Leading Brands Inc(LBIX)

Advisors’ Opinion:

  • [By Lisa Levin]

    Leading Brands, Inc (USA) (NASDAQ: LBIX) shares dropped 13 percent to $1.99 following Q2 results. Leading Brands posted Q2 EBITDAS of $0.00 per share, compared to $0.09 per share during the same period last year.

  • [By Lisa Levin]

    Leading Brands, Inc (USA) (NASDAQ: LBIX) shares were also up, gaining 145 percent to $3.31 on no formal news from company. The stock rallied 215 percent over Tuesday and Wednesday of this week amid trader speculation stock could be sympathy play on move higher in Helios & Matheson. However, Leading Brands shares sold off 27 percent on Thursday.

  • [By Lisa Levin]

    Leading Brands, Inc (USA) (NASDAQ: LBIX) shares shot up 66 percent to $2.49 following Q1 results. Leading Brands reported Q1 earnings of $0.10 per share on revenue of $3.033 million.

Top 10 Bank Stocks To Watch Right Now: Platform Specialty Products Corporation(PAH)

Advisors’ Opinion:

  • [By WWW.THESTREET.COM]

    In his second “Executive Decision” segment, Cramer spoke with Rakesh Sachdev, CEO of Platform Specialty Products (PAH) , the agriculture and industrial roll-up company which has seen its shares double over the past 12 months. Yesterday, Platform Specialty delivered a two-cents-a-share earnings beat.

  • [By Lee Jackson]

    Platform Specialty Products Corp. (NYSE: PAH) had a well-known seller parting with a huge chunk of stock. Bill Ackman’s Pershing Square hedge fund sold a total of 2,285,888 shares of the stock at $8.78 apiece. The total for the sale was posted at $20 million.The company produces and sells specialty chemical products in the Americas, the Asia-Pacific and Europe. The stock closed last Friday at $8.52.

Top 10 Bank Stocks To Watch Right Now: Sage Therapeutics, Inc.(SAGE)

Advisors’ Opinion:

  • [By Chris Lange]

    Shares of Sage Therapeutics Inc. (NASDAQ: SAGE) saw an incredible gain on Thursday after the firm announced positive top-line results from its midstage trial. Specifically, the firm reported results from its Phase 2 trial of Sage-217 for the treatment of moderate to severe major depressive disorder (MDD).

  • [By WWW.THESTREET.COM]

    The Good

    The market remains resistant (Rs over Ss and Ns). Brokerages, banks and insurance companies continue their league-leading strength. The Russell 2000 Index is up for the 15th consecutive day. Retail extends yesterday’s strength. Nordstrom (JWN) , Macy’s (M) , Best Buy (BBY) , Target (TGT) , Walmart (WMT) , Foot Locker (FL) and JCPenney (JCP) are strong. First day down for Amazon (AMZN) . Agricultural commodities are lackluster, but soybeans are up another up $0.05 today, up substantially for three days in a row. Speculative biotech (Sage (SAGE) , FibroGen (FGEN) , Acadia Pharmaceuticals (ACAD) and Aerie Pharmaceuticals  (AERI) ) stronger after recent weakness. Ag equipment up big time after the Deere (DE) beat.

    The Bad

  • [By WWW.THESTREET.COM]

    Position: Long GLD small, bonds, SDS; short TLT small, SPY small .

  • [By Lisa Levin]

    SAGE Therapeutics Inc (NASDAQ: SAGE) shares shot up 73 percent to $159.39 after the company disclosed that Phase 2 trial of SAGE-217 met its primary endpoint.

Top 10 Bank Stocks To Watch Right Now: Bonanza Creek Energy, Inc.(BCEI)

Advisors’ Opinion:

  • [By Paul Ausick]

    SandRidge Energy Inc. (NYSE: SD) emerged from an $8.3 billion bankruptcy in October 2016 while Bonanza Creek Energy Inc. (NYSE: BCEI) emerged in April after clearing up about $1.4 billion in debt. On November 15, SandRidge agreed to pay $746 million for Bonanza Creek and on November 22, Carl Icahn announced that he had acquired a 13.5% stake in SandRidge and said he intends to vote against the “nonsensical Bonanza transaction.”

  • [By Dustin Parrett]

    As a service to our readers, we’ve put together a list of 10 cheap oil stocks under $5. Here are the stocks, share prices, and year-to-date (YTD) returns for each:

    Vallourec Sp (OTCMKTS ADR: VLOWY); $1.42; +13.6% YTDIthaca Energy Inc. (TSE: IAE); $1.93; +14.5% YTDSandRidge Permian Trust (NYSE: PER); $3.45; +16.95% YTDGeopark Ltd. (NYSE: GPRK); $5.06; +17.4% YTDGastar Exploration Inc. (NYSEMKT: GST); $1.89; +22.26% YTDAscent Resources Plc. (LON: AST); $2.11; +25.53% YTDErin Energy Corp. (NYSEMKT: ERN); $3.94; +29.1% YTDChesapeake Granite Wash Trust (NYSE: CHKR); $3.25; +38.3% YTDSouthcross Energy Partners LP (NYSE: SXE); $2.27; +68.15% YTDBonanza Creek Energy Inc. (NYSE: BCEI); $2.27; +122.55% YTD

    This list of oil stocks contains some highly speculative plays, so we can’t recommend buying them.

  • [By Lisa Levin]

    Bonanza Creek Energy Inc (NYSE: BCEI) shares dropped 53 percent to $0.929 after the company reported that it has entered into a restructuring support agreement with bondholders holding more than $400 million in unsecured debt. The company also disclosed that it will commence its prepackaged bankruptcy case on or before January 5, 2017.

Top 10 Bank Stocks To Watch Right Now: Suncor Energy Inc.(SU)

Advisors’ Opinion:

  • [By Brian Feroldi, Chuck Saletta, Tyler Crowe, Jason Hall, and Jordan Wathen]

    With that in mind, we asked a team of Fools each to highlight a stock that a billionaire investor has been selling recently. Read on to see why they chose Cheniere Energy (NYSEMKT:LNG), Activision Blizzard (NASDAQ:ATVI), Suncor Energy (NYSE:SU), MGIC Investment Corporation (NYSE:MTG), and Extended Stay America (NYSE:STAY).

  • [By Shanthi Rexaline]

    The six companies that met the criterion are:

    Oshkosh Corp (NYSE: OSK). Phillips 66 (NYSE: PSX). SpartanNash Co (NASDAQ: SPTN). Suncor Energy Inc. (USA) (NYSE: SU). Washington Federal Inc. (NASDAQ: WAFD). Barnes & Noble, Inc. (NYSE: BKS).
    Oshkosh

    Oshkosh is a manufacturer of specialty vehicles and vehicle bodies and is based in Wisconsin. The company operates under four business segments, namely access equipment, defense, fire and emergency, and commercial.

  • [By Matthew DiLallo]

    In Canada, for example, the company and its partners Royal Dutch Shell (NYSE:RDS-A)(NYSE:RDS-B) and Suncor Energy (NYSE:SU) came up dry in their initial exploration attempts in the Shelburne Basin offshore Nova Scotia. The first noncommercial well forced Suncor Energy to write off 105 million Canadian dollars ($78.7 million) for its 20% stake in the well. Meanwhile, ConocoPhillips recorded a total of $187 million of dry hole expenses in Canada last year after it wrote off two wells.

Top 10 Bank Stocks To Watch Right Now: ImmunoCellular Therapeutics, Ltd.(IMUC)

Advisors’ Opinion:

  • [By Paul Ausick]

    ImmunoCellular Therapeutics Ltd. (NYSEMKT: IMUC) posted a new 52-week low of $0.48 on Tuesday, down nearly 61% compared with Monday’s closing price of $1.22. Volume totaled around 7.3 million shares, nearly 25 times the daily average. The company had no specific news Tuesday. The company price an offering of 5,000 preferred stock and warrants to purchase another 9,000 shares of preferred stock a $1,000 per share to raise approximately $5 million.

Top 10 Bank Stocks To Watch Right Now: Zosano Pharma Corporation(ZSAN)

Advisors’ Opinion:

  • [By Paul Ausick]

    Zosano Pharma Corp. (NASDAQ: ZSAN) dropped about 17% Tuesday to post a new 52-week low of $0.54 after closing at $0.65 on Friday. Volume was around 720,000, about 10% below the daily average of around 850,000. The company had no specific news.

  • [By Alex McGuire]

    Here’s a list of the top 10 penny stocks to watch in March, which includes the biggest gainers last month…

    Penny StockCurrent Stock PriceFebruary 2017 ReturnZosano Pharma Corp. (Nasdaq: ZSAN)$2.56+123.3%Bellerophon Therapeutics Inc. (Nasdaq: BLPH)$1.25+113.8%Peregrine Pharmaceuticals (Nasdaq: PPHM)$0.59+101.7%Galectin Therapeutics Inc. (Nasdaq: GALT)$1.79+91.9%Bioanalytical Systems Inc. (Nasdaq: BASI)$1.58+90.6%CymaBay Therapeutics Inc. (Nasdaq: CBAY)$3.50+89.8%Vermillion Inc. (Nasdaq: VRML)$2.56+86.3%Naked Brand Group Inc.(Nasdaq:NAKD)$2.16+76%Eyegate Pharmaceuticals Inc. (Nasdaq: EYEG)$2.63+73.9%Benitec Biopharma Ltd. (Nasdaq ADR: BNTC)$2.60+59.9%

    The best-performing penny stock – Zosano Pharma Corp. – soared an incredible 123.3% from Feb. 1 to Feb. 28. To put those gains into perspective, that’s more than five times the S&P 500’s 23% climb in the last 12 months.

Top 10 Bank Stocks To Watch Right Now: Powell Industries Inc.(POWL)

Advisors’ Opinion:

  • [By Lisa Levin]

    Shares of Powell Industries, Inc. (NASDAQ: POWL) were down 14 percent to $40.06. Powell Industries reported Q4 adjusted earnings of $0.54 per share on sales of $129.8 million.